期刊文献+

经不同途径应用万古霉素治疗兔细菌性脑室炎的效果

Effect of vancomycin administered via different ways on bacterial ventriculitis in adult rabbits
下载PDF
导出
摘要 目的探讨经不同途径应用万古霉素治疗兔细菌性脑室炎的效果。方法将新鲜配制的标准表皮葡萄球菌混悬液0.5 ml以0.1 ml/min的速度缓慢注入侧脑室将制作兔细菌性脑室炎模型。将50只细菌性脑室炎成年新西兰大白兔随机分为单纯静脉组(Ⅰ组,静脉注射万古霉素)、单纯动脉组(Ⅱ组,颈内动脉注射万古霉素)、联合静脉组(Ⅲ组,先静脉注射甘露醇,继而注射万古霉素)、联合动脉组(Ⅳ组,先颈内动脉注射甘露醇,继而注射万古霉素),对照组(Ⅴ组,静脉注射生理盐水),每组10只。所有动物均12 h给药一次,直至动物死亡,最多给药6次。结果Ⅰ组、Ⅱ组给药后96 h内无动物死亡,Ⅲ组给药后72~96 h死亡5只,Ⅳ组给药后72~96 h死亡1只,Ⅴ组给药后24 h内全部死亡。首次给药后1 h,Ⅰ、Ⅱ、Ⅲ、Ⅳ组脑脊液万古霉素浓度分别为(40.02±0.07)μg/L、(89.11±0.19)μg/L、(69.02±0.17)μg/L、(118.13±0.31)μg/L;两两比较,均有统计学差异(P<0.05)。给药72、96 h,Ⅳ组肛温、外周血白细胞数、脑脊液白细胞数均明显低于Ⅲ组(P<0.05)。结论经颈内动脉联合应用甘露醇和万古霉素治疗细菌性脑室炎的效果优于单纯静脉或动脉注射万古霉素以及经静脉联合应用甘露醇和万古霉素的效果。 Objective To investigate the effect of vancomycin administered via different ways on bacterial ventriculitis in adult rabbits. Methods Fifty adult rabbits with bacterial ventriculitis established by injection of Staphylococcus epidermidis suspension into the cella lateralis of rabbits were randomly divided into 5 groups of 10 animals each, i.e. group Ⅰ in which the animals received intravenous injection of vacomycin, group Ⅱ in which the animals received intraarterial injection of vacomyin, group Ⅲ in which the animals received intravenous injection of vacomycin after the intravenous infusion of mannitol, group Ⅳ in which the animals received intraarterial injection of vacomycin after the intraarterial infusion of mannitol and group V in which the animals received intravenous injection of physiological saline. The treatment (once every 12 hours and total 6 times) began after blood and cerebrospinal fluid (CSF) samples were taken. The rectal temperature and rate of animal survival were observed in all the groups. The concentration of vancomycin in CSF was measured, and routine examinations of blood and CSF were performed in all the animals. Results The CSF concentration of vancomycin in group Ⅳ is the highest among these 5 groups after the first administration of vacomycin (P<0.05). The rate of animal survival was 90%(9/10) in group Ⅳ, it was 50%(5/10) in the group Ⅲ and all the animals dead in group Ⅰ,Ⅱ and Ⅴ 96 hours after the treatment. The rectal temperature and numbers of blood and CSF leukocytes were significantly lower in group Ⅳ than those in group Ⅲ 96 hours after the treatment (P<0.05). Conclusion It is suggested that the intraarterial injection of vacomycin after the intraarterial injection of mannitol may enhance the curative effects of the vacomycin on the bacterial ventriculitis compared to simple intraarterial injection or intravenous injection of the vacomycin after the intravenous injection of mannitol.
作者 原高明 孟晓峰 郭孝龙 崔涛 程小兵 郝晓伟 李泓江 史保中 YUAN Gao-ming;MENG Xiao-feng;GUO Xiao-long;CUI Tao;CHENG Xiao-bing;HAO Xiao-wei;LI Hong-Jiang;SHI Baozhong(Department of Neurosurgery,the First Affiliated Hospital,Henan University of Sciences and Technology,Luoyang 471003,China;Department of Neurosurgery,Shanghai Ninth People's Hospital,Medical School,Shanghai Jiaotong University,Shanghai 200011,China)
出处 《中国临床神经外科杂志》 2019年第7期422-424,共3页 Chinese Journal of Clinical Neurosurgery
关键词 细菌性脑室炎 甘露醇 万古霉素 Ventriculitis Vacomycin Administration Mannitol Rabbits
  • 相关文献

参考文献5

二级参考文献22

  • 1胡学强,王世芳,陆正齐.尿激酶联合自体血浆治疗实验性兔脑室出血[J].中国脑血管病杂志,2004,1(7):313-316. 被引量:2
  • 2杜浩,秦尚振,马廉亭,潘力,李爱冰.脑室-腹腔分流术后颅内感染的原因及治疗措施[J].中国临床神经外科杂志,2004,9(5):335-337. 被引量:29
  • 3李小勇,王忠诚,李银平,马震宇,杨俊,曹尔澄.脑积水脑室腹腔分流相关性脑室炎治疗方案的探讨[J].中国危重病急救医学,2005,17(9):558-560. 被引量:19
  • 4汤浩,雷霆,李龄.脑积水分流术后感染的研究新进展[J].中国临床神经外科杂志,2005,10(6):472-474. 被引量:23
  • 5[1]Bhattacharjee AK, Nagashina T, Kondoh T,et al. Quantification of early blood brain barrier disruption by in situ brain perfusion technique[J]. Brain Res Protoc ,2001,8(2):126-131.
  • 6[2]Pan GY, Liu XD, Liu GQ. Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats[J]. Acta Pharmacol Sin,2000,21(7):613-616.
  • 7[3]Bhattacharjee AK, Nagashina T, Kondoh T, et al. The effects of the Na+/Ca++exchange blocker on osmotic blood-brain barrier disruption[J]. Brain Res, 2001,900(2):157-162.
  • 8[4]Rapoport SI. Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy [J]. Brain Res, 2001,10(10):1809-1818.
  • 9[4]ww.fda.gov/cder/cancer/animalframe.htm
  • 10[5]FDA Guidance for industry and reviewers: Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers[ S]. 2002; 12

共引文献1424

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部